SP2 Therapeutics is redefining peptide synthesis, addressing core biopharmaceutical production challenges. Our patent-protected FLOWSMART system combines Nobel-prize winning solid phase peptide synthesis with AI-guided, resin-based flow chemistry, achieving massive cost savings and scalability. SP2 Therapeutics is a spinout from Seoul National University's renowned Institute of Molecular Biology and Genetics. Our core team’s expertise spans diverse domains such as resin-based chemistry, bioinformatics, engineering, and machine learning. Our FLOWSMART synthesis platform can greatly accelerate your peptide drug development efforts.
Company Details
- Employees
- 7
- Founded
- 2022
- Address
- Seoul, Kr
- Industry
- Biotechnology
- Website
- http://www.sp2tx.com
- HQ
- Seoul
Sp2tx Questions
Sp2Tx's website is http://www.sp2tx.com
Sp2Tx's LinkedIn profile is https://www.linkedin.com/company/sp2tx
Sp2Tx has
7 employees.
View email and phone details for 7
employees at Sp2Tx.
Sp2Tx's industry is
Biotechnology
Sp2Tx's top competitors are
Genesystem,
Glory Biotech Corp.,
Dna Reference Lab Inc,
The Neurodevelopmental Institute Of Nh, Llc,
Abclonal Korea,
Lpt - Laboratory Of Pharmacology And Toxicology Gmbh & Co. Kg,
Geneall Biotechnology,
Anygen Co., Ltd.,
Js Link Sequencing Lab (Formerly Dna Link),
Labiskoma.
Sp2Tx's categories are Biotechnology
Sp2Tx's founding year is 2022
